Irlanda - inglés - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - cefotaxime sodium - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; cefotaxime

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - cefotaxime sodium - powder for solution for injection/infusion - 500 milligram(s) - third-generation cephalosporins; cefotaxime

Estados Unidos - inglés - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - allopurinol sodium (unii: 428673rc2z) (allopurinol - unii:63cz7gjn5i) - allopurinol 500 mg in 25 ml - allopurinol sodium for injection is indicated for the management of adult and pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy. allopurinol sodium for injection is contraindicated in patients with a history of severe reaction to any formulation of allopurinol. based on findings in animals, allopurinol sodium for injection may cause fetal harm when administered to a pregnant woman. adverse developmental outcomes have been described in exposed animals (see data) . allopurinol and its metabolite oxypurinol have been shown to cross the placenta following administration of maternal allopurinol. available limited published data on allopurinol use in pregnant women do not demonstrate a clear pattern or increase in frequency of adverse developmental outcomes. among approximately 50 pregnancies described in published literature, 2 infants with major congenital malf

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefotaxime sodium 524 mg - eq. cefotaxime 500 mg - powder for solution for injection/infusion - 0,5 g - cefotaxime sodium 524 mg - cefotaxime

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefotaxime sodium 1,048 g - eq. cefotaxime 1 g - powder for solution for injection/infusion - 1 g - cefotaxime sodium 1.048 g - cefotaxime

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefotaxime sodium 2,096 g - eq. cefotaxime sodium 2 g - powder for solution for injection/infusion - 2 g - cefotaxime sodium 2.096 g - cefotaxime

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - cefotaxime sodium 1048mg equivalent to 1 g cefotaxime - powder for injection - 1 g - active: cefotaxime sodium 1048mg equivalent to 1 g cefotaxime excipient: nitrogen

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - cefotaxime sodium 2097mg equivalent to 2 g cefotaxime - powder for injection - 2 g - active: cefotaxime sodium 2097mg equivalent to 2 g cefotaxime excipient: nitrogen

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - cefotaxime sodium 524mg equivalent to 500 mg cefotaxime - powder for injection - 500 mg - active: cefotaxime sodium 524mg equivalent to 500 mg cefotaxime

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - cefotaxime sodium 1048.2mg equivalent to 1000 mg cefotaxime;   - powder for injection - 1000 mg - active: cefotaxime sodium 1048.2mg equivalent to 1000 mg cefotaxime